Skip to main content

Table 1 Average control values in patients from 2018 to 2022

From: Effect of the SARS-CoV-2 pandemic on metabolic control in patients with type 2 diabetes: a 5-year cohort follow-up managed by a dynamic multidisciplinary team in Northeastern Mexico

Laboratory Parameter Mean (SD)

Beginning 2018

End of 2018

Beginning 2019

End of 2019

Beginning 2020

End of 2020

Beginning 2021

End of 2021

Beginning 2022

End of 2022

p-value

Fasting Serum Glucose (mg/dL)

163.8 (1.3)a

n = 796

159.8 (1.3)a

n = 775

124.9 (1.4)b

n = 869

126.5 (1.4)b

n = 890

127.9 (1.4)c

n = 768

126.0 (1.4)c

n = 843

128.5 (1.4)c n = 833

124.8 (1.3)c n = 479

132.3 (1.4)b n = 747

130.2 (1.4)b n = 726

 < 0.001

Glycated Hemoglobin

(%)

7.3

(1.2) n = 888

7.4

(1.2) n = 582

7.2

(1.2) n = 320

7.2

(1.2) n = 956

7.3

(1.2) n = 406

7.1

(1.2) n = 130

7.4

(1.2) n = 747

7.1

(1.2) n = 578

7.3

(1.2) n = 603

7.1 (1.2) n = 693

0.941

Total Cholesterol (mg/dL)

166.9 (1.2) n = 795

163.6 (1.2) n = 771

165.5 (1.3) n = 772

165.1 (1.3) n = 837

164.7 (1.3) n = 718

160.7 (1.3) n = 830

162.2 (1.2) n = 725

161.5 (1.2) n = 502

159.0 (1.3) n = 476

162.2 (1.3) n = 558

0.660

HDL-C (mg/dL)

41.4

(1.3) n = 660

41.9 (1.3) n = 619

42.0

(1.3) n = 620

42.6 (1.3) n = 679

42.8

(1.2) n = 568

43.0 (1.3) n = 710

43.4

(1.3) n = 649

44.5 (1.3) n = 313

44.5

(1.3) n = 621

45.2 (1.3) n = 570

0.102

LDL-C (mg/dL)

88.6

(1.4) n = 654

86.3 (1.4) n = 611

86.1

(1.5) n = 617

87.8 (1.5) n = 679

95.3

(1.4) n = 566

93.9 (1.4) n = 704

91.4

(1.4) n = 645

93.1 (1.5) n = 318

95.5

(1.4) n = 308

90.4 (1.4) n = 567

0.368

Triglycerides (mg/dL)

151.9 (1.6) n = 660

142.2 (1.6) n = 622

151.8 (1.6) n = 628

144.4 (1.6) n = 690

149.1 (1.6) n = 574

147.6 (1.7) n = 712

151.6 (1.7) n = 650

159.7 (1.7) n = 316

150.6 (1.7) n = 603

149.9 (1.6) n = 570

0.834

Systolic blood pressure (mmHg)

123.2 (1.1) n = 681

122.8 (1.1) n = 670

122.8 (1.1) n = 684

122 (1.1) n = 455

119.9 (1.1) n = 237

120.7 (1.1) n = 147

122.5 (1.1) n = 523

122.3 (1.1) n = 610

124.0 (1.1) n = 777

122.8 (1.1) n = 799

0.799

Diastolic blood pressure (mmHg)

74.3

(1.1) n = 683

73.8 (1.1) n = 670

74.0

(1.1) n = 685

72.2 (1.1) n = 456

71.6

(1.1) n = 236

70.8 (1.1) n = 148

75.1

(1.1) n = 512

74.9 (1.1) n = 609

74.7

(1.1) n = 776

73.3 (1.1) n = 799

0.133

Body mass index (kg/m2)

31.4

(1.2)

n = 383

31.1 (1.2)

n = 395

31.2

(1.2)

n = 486

31.0 (1.2)

n = 818

31.2

(1.2)

n = 736

31.1 (1.2)

n = 148

31.1

(1.2)

n = 196

30.2 (1.2)

n = 297

30.4

(1.2)

n = 489

30.3 (1.2)

n = 678

0.636*

  1. A p-value was obtained through repeated measures ANOVA or through Friedman test (*) depending on normality. A p-value < 0.05 was considered significant. Post HOC analysis using the Sidak method denoted by 'ab. Variables with the same letter indicate no significant difference, while variables with different letters indicate a significant difference